Latest Advances

  • Journal: Scientific reports
  • Published —
HLA-B27 is associated with reduced disease activity in axial spondyloarthritis.
  • Condition: Enthesitis in Patients with Axial Spondyloarthritis (SpA)
  • Journal: Arthritis research & therapy
  • Treatment Used: Tumor Necrosis Factor Inhibitors (TNFis)
  • Number of Patients: 1668
  • Published —
This study investigated the evolution of enthesitis following tumor necrosis factor inhibitor (TNFi) initiation in the treatment of patients with spondyloarthritis (spinal arthritis; SpA).
  • Condition: Axial Spondyloarthritis (axSpA)
  • Journal: Current rheumatology reports
  • Treatment Used: JAK Inhibitors (JAKis)
  • Number of Patients: 0
  • Published —
This article discusses the possible role of JAK inhibitors (JAKis) as new medications for the treatment of patients with axial spondyloarthritis (axSpA).
  • Condition: Spondyloarthritis
  • Journal: Medicine
  • Treatment Used: Golimumab as Second Biological Drug
  • Number of Patients: 210
  • Published —
This study evaluated the effectiveness of golimumab as a second biological drug for the treatment of patients with spondyloarthritis.
  • Condition: Axial Spondyloarthritis (axSpA)
  • Journal: Advances in rheumatology (London, England)
  • Treatment Used: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • Number of Patients: 0
  • Published —
This article provides guidelines for the treatment of patients with axial spondyloarthritis (axSpA) with nonsteroidal anti-inflammatory drugs (NSAIDs).
  • Journal: BMJ (Clinical research ed.)
  • Published —
Axial spondyloarthritis: new advances in diagnosis and management.
  • Condition: Axial Spondyloarthritis
  • Journal: Rheumatology (Oxford, England)
  • Treatment Used: NSAIDs
  • Number of Patients: NULL
  • Published —
The study researched treatment of axial spondyloarthritis.
  • Condition: Axial Spondyloarthritis
  • Journal: RMD open
  • Treatment Used: Secukinumab
  • Number of Patients: 1860
  • Published —
This study explored the effectiveness of 6-month and 12-month secukinumab in patients with axial spondyloarthritis (spinal degeneration; axSpA).
  • Condition: Axial Spondyloarthritis
  • Journal: Arthritis research & therapy
  • Treatment Used: TNF Inhibitors
  • Number of Patients: 193
  • Published —
This study investigated if switching TNF inhibitors after a primary or secondary failure provides good clinical outcomes in patients with axial spondyloarthritis.
  • Condition: Axial Spondyloarthritis
  • Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
  • Treatment Used: Serial Locally Applied Water-filtered Infrared a Radiation (sl-wIRAR)
  • Number of Patients: 71
  • Published —
In this study, researchers evaluated the outcomes of using serial locally applied water-filtered infrared A radiation (sl-wIRAR) for the treatment of axial spondyloarthritis.
Showing 1-12 of 40